VolitionRx Ltd
VNRX
36 hedge funds and large institutions have $15M invested in VolitionRx Ltd in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
16% more funds holding
Funds holding: 31 → 36 (+5)
0.01% more ownership
Funds ownership: 0.38% → 0.39% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less capital invested
Capital invested by funds: $17.5M → $15M (-$2.44M)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$279K |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
+$106K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
+$103K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$63.6K |
| 5 |
State Street
Boston,
Massachusetts
|
+$63.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$124K |
| 2 |
VF
Virtu Financial
New York
|
-$113K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$91K |
| 4 |
Renaissance Technologies
New York
|
-$77.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$64.4K |
VNRX Hedge Fund Activity: Q4 2019 in Review
36 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2019, worth a combined $15M — down 14% from $17.5M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new VNRX positions and 3 closed out — a net gain of 5 holders — while 6 added to existing stakes and 8 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $279K. The largest seller was JP Morgan Chase, cutting an estimated $124K.
- 36 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2019, up from 31 in Q3 2019.
- Funds reported $15M of VolitionRx Ltd stock for Q4 2019, down 14% quarter-over-quarter.
- 8 funds opened new VolitionRx Ltd positions in Q4 2019 and 3 closed out, a net change of +5 holders.
- The largest VolitionRx Ltd buyer in Q4 2019 was Morgan Stanley, an estimated $279K added.
- The largest VolitionRx Ltd seller in Q4 2019 was JP Morgan Chase, an estimated $124K sold.
Based on aggregated 13F filings for Q4 2019.